Direct Meds vs Luvo Health
Direct Meds has an open FDA warning letter dated September 9, 2025. Luvo Health has none. On compounded tirzepatide injection, Luvo Health costs $2,461 less a year at standing rates: $179 a month (billed every 4 weeks) against $399 a month at Direct Meds. It is one of three products the two sell at comparable terms.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Direct Meds / Luvo Health
Direct Meds
7.1/10
Luvo Health
7.9/10
Both Direct Meds and Luvo Health are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Direct Meds 7.1, Luvo Health 7.9). How we are paid
What the record shows
- 01
Direct Meds has an open FDA warning letter dated September 9, 2025. Luvo Health has none.
- 02
Neither names the pharmacy that compounds its medication.
- 03
On compounded tirzepatide injection, Luvo Health costs $2,461 less a year at standing rates: $179 a month (billed every 4 weeks) against $399 a month at Direct Meds. It is one of three products the two sell at comparable terms.
- 04
Only Direct Meds lists a price for compounded oral tirzepatide. Only Luvo Health lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.
- 05
Luvo Health covers two states Direct Meds does not.
- 06
Direct Meds holds you to a 90-day supply shipped at once, remaining months billed every 30 days; Luvo Health states you can cancel at any time.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Direct Meds
Luvo Health
$297/mo
$3,564 a year
$179/moLower
$2,148 a year
$399/mo
$4,788 a year
$179/moLower
$2,327 a year, 13 charges
$249/moLower
$2,988 a year
$259/mo
$3,108 a year
$1,299/mo
$15,588 a year
$1,399/mo
$16,788 a year
$299/mo
$3,588 a year
Read off each seller’s own pages. Direct Meds: October 17, 2026. Luvo Health: October 17, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Direct Meds
7.1/10- $120 a year less on compounded oral semaglutide
- Sells compounded oral tirzepatide, which Luvo Health does not price
- Open FDA warning letter, September 9, 2025
- Names no compounding pharmacy
- Minimum commitment before you can cancel
The case for Luvo Health
7.9/10- No FDA warning letter on record
- $1,416 a year less on compounded semaglutide injection
- $2,461 a year less on compounded tirzepatide injection
- Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Direct Meds does not price
- Names no compounding pharmacy
Scores
Direct Meds 7.1 · Luvo Health 7.9 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Direct Meds vs Luvo Health: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Gala8.5
From $179/mo
Visit site - Eden8.7
From $99/mo
Visit site - YourEra9.0
From $99/mo
Visit site
Sellers closest to these two
- Direct Meds vs Henry Meds
- Direct Meds vs Fridays
- Direct Meds vs RxSpan MD
- Direct Meds vs Wellorithm
- Luvo Health vs Gala
- Luvo Health vs Embody
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks